Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556722/
https://www.ncbi.nlm.nih.gov/pubmed/34729014
http://dx.doi.org/10.2147/OTT.S343977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556722/
https://www.ncbi.nlm.nih.gov/pubmed/34729014
http://dx.doi.org/10.2147/OTT.S343977

Ejemplares similares